Where Care Excellence Meets Business Success. Transform your operations today - 0333 577 0877
We are here to help 24/7.

AwardBlood analysis servicesCPV: 85111810

Blood Group Genotyping for Sickle Cell and Thalassaemi

Leeds
NHS BLOOD AND TRANSPLANT (NHSBT
Published 3 Sept, 2025
Contract Value
£140,671
View Official Notice

Overview

Summary, notice description and lot information

Summary of the contracting process

NHS England, Leeds, has completed a procurement process for the service titled "Blood Group Genotyping for Sickle Cell and Thalassaemia". As the buyer, NHS England sought to embed blood group genotyping into routine medical practice, primarily to minimise adverse reactions in patients with rare blood disorders. This contract falls under the "Blood analysis services" category and covers the region of England, United Kingdom, specifically at the postal code LS1 4AP.

The procurement process reached the award stage on 13th May 2025 and the contract runs from 12th May 2025 to 31st March 2026. With a total procurement value of £140,671, this tender was successfully awarded to NHS Blood and Transplant (NHSBT). The procurement method is labelled as 'Other', indicating a specialised approach tailored to the service's specific requirements.

This procurement opportunity presents significant growth potential for businesses specialising in medical and laboratory services, particularly those capable of advancing blood genotyping. Small and medium enterprises (SMEs) as well as voluntary, community, and social enterprises (VCSEs) would find this opportunity fitting due to the tailored requirements and the chance to collaborate with leading healthcare organisations like NHSBT. Engaging in such procurement processes not only provides financial growth but also enhances business credibility and industry standing through association with nationally significant healthcare projects.

Prospective firms engaging in similar opportunities should focus on innovation in medical technology and robust service provision capabilities.

Notice Description

The main output of this programme is for blood group genotyping to become embedded into routine practice. Primary objective (benefit) of doing so is to ensure patients with rare blood disorders have a minimise risk of adverse reactions through access to blood group genotyping.

Lot Information0 Lots
No lot information available.

Procurement Classification

Notice type, method, and CPV codes

Open Contracting ID
ocds-b5fd17-4ae36907-e480-42d5-845e-5aaee77248d4
Publication Source
Contracts Finder
Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Not Specified
Awardee Scale
SME
Current Stage
Award

Contract Values

Financial information and value estimates

Tender Value
£140,671
Lots Value
Not specified
Awards Value
£140,671
Contracts Value
Not specified

The contract period is one year.

Key Dates

Publication, submission, and award timeline

Notice Status

Current status of tender, lots, awards, and contracts

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Contracting Authority

Buyer organisation and contact details

NEL
NHS ENGLAND, LEEDS
Services
Contact Name
Pratim Saikia
LEEDS
LS1 4AP
Yorkshire and The Humber
England
TLE4 West Yorkshire

Awarded Supplier

Supplier who was awarded this contract

NB
NHS BLOOD AND TRANSPLANT (NHSBTAwarded
SME
View Profile
Number of Suppliers
1
Awards Value
£140,671

Documents & Links

External resources and data downloads

Open Contracting Data Standard (OCDS)
OCDS RecordID: ocds-b5fd17-4ae36907-e480-42d5-845e-5aaee77248d4

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector.

Need help with your tender submission?

Our expert team can help you prepare a winning bid. Get professional support from CareSync Experts.

Get in touch with our team at Care Sync Experts today for a consultation.

Email: hello@caresyncexperts.co.uk

Phone: 0333 577 0877

Contact Us